CSBR:NASDAQ
Champions Oncology Inc
US$4.67
arrow_upward
+0.43%(+0.020) 1D
ኖቬም 13, 12:14:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$4.57
High
US$4.67
Low
US$4.52
Mkt. cap
65.00 ሚ
Avg. vol.
8.16 ሺ
Volume
1.09 ሺ
52-wk high
US$8.31
52-wk low
US$4.52
EPS
-US$0.08
Beta
0.47
Shares outstanding
13.92 ሚ
No. of employees
217
Open
US$4.57
High
US$4.67
Low
US$4.52
Mkt. cap
65.00 ሚ
Avg. vol.
8.16 ሺ
Volume
1.09 ሺ
52-wk high
US$8.31
52-wk low
US$4.52
EPS
-US$0.08
Beta
0.47
Shares outstanding
13.92 ሚ
No. of employees
217
News stories
From web sources and news partners
Yahoo Finance
·
ከ1 ሰዓት በፊት
The S&P 500 Has a “Pure Value” Version. RPV Gives Its Cheapest Stocks the Biggest Weights
24/7 Wall St.
·
ከ1 ሰዓት በፊት
S&P 500 Slides Nearly 1% at Midday as Tech Absorbs Most of the Hit
Reuters
·
ከ3 ሰዓቶች በፊት
Goldman Sachs sees S&P 500 rising to 8,700 next year despite slower earnings growth
StoneX
·
ከ33 ደቂቃዎች በፊት
S&P 500 forecast: SPX struggles for direction ahead of PPI data
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ኒው ጄርዚ, ዩናይትድ ስቴትስ
SectorHealth Care
Industry-
Websitechampionsoncology.com